Crescent Capital BDC (CCAP) to Release Earnings on Wednesday

Crescent Capital BDC (NASDAQ:CCAP) is anticipated to issue its Q4 2025 results after the market closes on Wednesday, February 18th. Analysts expect the company to announce earnings of $0.44 per share and revenue of $39.83 million for the quarter. Individuals are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Thursday, February 26, 2026 at 12:00 PM ET.

Crescent Capital BDC (NASDAQ:CCAP) last announced its quarterly earnings data on Wednesday, November 12th. The company reported $0.46 earnings per share for the quarter, missing the consensus estimate of $0.47 by ($0.01). The firm had revenue of $41.35 million for the quarter, compared to analyst estimates of $42.35 million. Crescent Capital BDC had a return on equity of 9.76% and a net margin of 20.84%.

Crescent Capital BDC Stock Performance

CCAP opened at $14.23 on Wednesday. The stock’s 50 day simple moving average is $14.53 and its 200-day simple moving average is $14.57. The company has a current ratio of 1.20, a quick ratio of 1.20 and a debt-to-equity ratio of 1.23. The stock has a market cap of $526.37 million, a PE ratio of 14.52 and a beta of 0.55. Crescent Capital BDC has a 1 year low of $13.03 and a 1 year high of $20.19.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Northwestern Mutual Wealth Management Co. bought a new stake in Crescent Capital BDC during the 4th quarter worth about $27,000. VPR Management LLC raised its stake in shares of Crescent Capital BDC by 150.0% in the third quarter. VPR Management LLC now owns 5,000 shares of the company’s stock worth $71,000 after acquiring an additional 3,000 shares during the last quarter. Permanens Capital L.P. acquired a new position in shares of Crescent Capital BDC during the third quarter worth approximately $147,000. XTX Topco Ltd acquired a new position in shares of Crescent Capital BDC during the second quarter worth approximately $165,000. Finally, Seven Mile Advisory bought a new stake in shares of Crescent Capital BDC during the third quarter valued at approximately $189,000. 49.46% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on CCAP shares. Wall Street Zen raised shares of Crescent Capital BDC from a “sell” rating to a “hold” rating in a report on Saturday, January 10th. Keefe, Bruyette & Woods dropped their price target on shares of Crescent Capital BDC from $17.00 to $15.50 and set an “outperform” rating for the company in a research report on Friday, November 14th. Zacks Research cut shares of Crescent Capital BDC from a “hold” rating to a “strong sell” rating in a research note on Monday, January 12th. Wells Fargo & Company lowered their price objective on Crescent Capital BDC from $15.00 to $14.00 and set an “equal weight” rating on the stock in a research note on Friday, November 14th. Finally, Oppenheimer dropped their target price on Crescent Capital BDC from $20.00 to $19.00 and set an “outperform” rating for the company in a report on Friday, November 14th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $16.38.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is a closed-end, externally managed business development company that provides flexible financing solutions to middle market companies in the United States. Trading on the Nasdaq under the ticker CCAP, the firm offers investors exposure to a diversified portfolio of debt and equity instruments, targeting businesses with attractive risk-adjusted return profiles. Its primary objective is to generate current income through interest payments and potential capital appreciation via selective equity co-investments.

The company’s investment strategy emphasizes senior secured loans, unsecured second-lien loans, mezzanine debt, as well as preferred and common equity co-investments.